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INTRODUCTION
The impact of neonatal pain on developing nociceptive circuitry, 
 nociceptive processing and the subsequent perception of pain has 
been the focus of a signifi cant amount of research within the last dec-
ade. Evidence from clinical and animal research suggests that exposure 
to noxious stimuli early in life may result in lasting changes in sen-
sory processing (Grunau et al., 1994a; Ren et al., 2004; LaPrairie and 
Murphy, 2007). For example, in preterm infants, a higher frequency 
of invasive procedures is associated with signifi cantly dampened 
pain responses at 32 weeks of age (Grunau et al., 2001). Moreover, 
premature infants with NICU experience display decreased behav-
ioral responses to heel-lance and inoculation at 8 months (Johnston 
et al., 1996; Oberlander et al., 2000), and are rated by parents as less 
sensitive to pain compared to children with no NICU experience 
at 18 months of age (Grunau et al., 1994b). Indeed, alterations in 
nociception are not transient in nature, such that both full- and 
preterm infants with prior NICU experience display decreased pain 
sensitivity at 14 years of age (Hermann et al., 2006).
Consistent with the human literature, experimental animal 
studies have also shown that neonatal noxious insult induces 
widespread changes in nociceptive processing. For example, in rats, 
neonatal intraplantar infl ammation induces long-lasting and sig-
nifi cant hypoalgesia in both the previously injured and uninjured 
paws, and changes in pain sensitivity have been reported for the 
tail and viscera as well (Al-Chaer et al., 2000; Ren et al., 2004; Wang 
et al., 2004; DeBerry et al., 2007; LaPrairie and Murphy, 2007). 
A generalized decrease in nociceptive sensitivity as a consequence of 
repetitive foot shock, surgical incisions, and intraplantar formalin 
injections has also been reported (Shimada et al., 1990; Bhutta et al., 
2001; Sternberg et al., 2005). In addition, neonatally injured rats 
display a hypersensitive response following re-injury in adulthood 
and a signifi cantly reduced rate of recovery, with similar fi ndings 
reported in humans (Ren et al., 2004; LaPrairie and Murphy, 2007). 
Interestingly, all of these long-term consequences associated with 
neonatal infl ammatory insult are exacerbated in females (LaPrairie 
and Murphy, 2007). To date, however, the mechanisms underlying 
neonatal injury-induced changes in sensory processing have yet to 
be elucidated.
The objective of the present study was to determine if the long-
term decreases in nociceptive responsiveness induced by neonatal 
infl ammatory insult are due to alterations in endogenous pain mod-
ulation. Behavioral and anatomical studies were conducted to test 
our hypothesis that neonatal injury-induced hypoalgesia is medi-
ated by an increase in central opioid tone resulting from increased 
activation of descending nociceptive inhibitory pathways.
MATERIALS AND METHODS
SUBJECTS
Time-pregnant Sprague-Dawley rats (Zivic Miller) were obtained 
on the 14th day of gestation (E14) and housed individually. Animals 
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were maintained on a 12:12 h light:dark cycle, with food and water 
available ad libitum. All litters were reared identically, weaned at 
P21, and housed with same-sex littermates in groups of 2–3. All 
experiments were approved by the Georgia State University Animal 
Care and Use Committee and were conducted in strict compliance 
with the guidelines for pain research established by the International 
Association for the Study of Pain (IASP).
EARLY LIFE MANIPULATIONS
Acute neonatal infl ammation was induced by unilateral injection 
of carrageenan (CGN; 1% soln in saline; 5 µl; Sigma, St. Louis MO) 
into the plantar surface of the right hindpaw within 12 h of birth on 
P0. This infl ammatory agent provides a well-established model of 
acute local infl ammatory pain that persists for 12–72 h (Ren et al., 
2004). Control animals received intraplantar sterile saline or were 
“handled” in a similar manner and returned to their home cage.
NOCICEPTIVE BEHAVIORAL TESTING
Thermal testing was conducted using the Paw Thermal Stimulator 
(UCSD, San Diego, CA, USA). Briefl y, animals were placed in a clear 
plastic testing chamber on a glass surface and allowed to acclimate 
for a minimum of 30 min prior to testing. A radiant beam of light 
beneath the glass base was directed at the plantar surface of the each 
hindpaw and the withdrawal refl ex latency was electronically meas-
ured (in seconds) (Hargreaves et al., 1988). Intact male and cycling 
female rats were tested separately. The average withdrawal latency of 
three trials was taken; all trials were separated by a 5-min inter-trial 
interval. Application of the thermal stimulus to either the left (previ-
ously uninjured) or right (previously injured) paw was randomly 
determined. While hypoalgesia is present in both paws (LaPrairie 
and Murphy, 2007), only right paw latencies are reported here. To 
avoid potential tissue damage, a 20-s automatic termination of the 
heat stimulus (approximately 2× baseline latency) was imposed if a 
paw withdrawal did not occur. The testing apparatus was thoroughly 
cleaned between sessions. The same investigator whom was blinded 
to the neonatal treatment conducted all behavior tests.
DRUG ADMINISTRATION
To test the hypothesis that neonatal injury-induced hypoalgesia was 
due to increased endogenous opioid tone, naloxone HCl (1 mg kg 
s.c.; Sigma, St. Louis, MO, USA) dissolved in saline to desired con-
centration was administered 10 min prior to paw withdrawal latency 
(PWL) determination on P60. To test whether alterations in opioid 
tone were peripherally mediated, the peripherally restricted opioid 
antagonist, naloxone methiodide (1 mg/kg s.c.; Sigma, St. Louis, 
MO, USA), was administered systemically 15 min prior to testing 
in adulthood. The doses used were selected based on our previous 
studies (Ji et al., 2006; LaPrairie and Murphy, 2007).
For intracerebroventricular (i.c.v.) or intra-PAG injections, intact 
males (n = 48) and cycling females (n = 52) were deeply anesthe-
tized with a cocktail of ketamine/xylazine/acepromazine (50 mg/
kg/3.3 mg/kg/3.3 mg/kg; i.p.; Henry Shein, Melville, NY, USA) 
and placed in a stereotaxic frame. A guide cannula (22G, C313G, 
PlasticOne Inc, Roanoke, VA, USA) was implanted at the following 
coordinates (mm) for i.c.v. injections: Bregma: −1.0; mediolateral: 
1.4; dorsoventral: 3.6. For PAG injections, a guide cannula was 
implanted at the following coordinates: lambda: +0.50; mediolateral: 
0.65; dorsoventral: 5.8 as previously described (Loyd et al., 2008). 
PAG injections were unilateral, with the cannula located ipsilateral 
to the injured paw (right side). The ventrolateral PAG was targeted 
for injection as this region contains a high density of mu opioid 
receptors (Wang and Wessendorf, 2002).
On P60, naloxone HCl was injected i.c.v. (1.0 µg/2.0 µl; Sigma, 
St. Louis, MO, USA) over a 2-min period. In subsequent  experiments 
the following opioid antagonists were administered intra-PAG: 
naloxone (0.5 µg/0.5 µl), mu antagonist CTOP (0.5 µg/0.5 µl 
and 7.5 µg/0.5 µl), delta antagonist naltrindole (0.5 µg/0.5 µl and 
7.5 µg/0.5 µl) and kappa antagonist nor-BNI (7.5 µg/0.5 µl). All 
antagonists were gifts from NIDA. Mu and delta antagonists and 
doses were administered in random order 15 min prior to testing. 
As nor-BNI is a permanent antagonist, all animals received this 
antagonist last (Craft et al., 2001). As a positive control, a separate 
group of animals were only administered nor-BNI. Nor-BNI was 
administered and testing followed 24 h later (Craft et al., 2001). Paw 
withdrawal latencies in response to noxious thermal stimulation 
were determined at 15, 30, 45, 60, 90 and 120 min post-injection. 
A minimum 72-h washout period between all drugs and doses 
was imposed. Injection sites were determined by administration 
of Pontamine Sky Blue (0.5 µl, PAG; 2.0 µl, i.c.v.; Sigma Aldrich, 
USA) at the completion of the experiment. Brains were removed, 
sectioned, and sections mounted onto slides; all injections sites 
were verifi ed histologically. Only animals with injection sites into 
the lateral ventricle or ventrolateral PAG (Bregma: −7.64 to −8.30) 
were used for further analysis.
PERFUSION FIXATION
At P60, a separate group of neonatally manipulated animals that 
were not used in the behavioral experiments were given a euthaniz-
ing dose of Nembutal (160 mg/kg; i.p.), and then perfused tran-
scardially (descending aorta clamped) with 200 ml of 0.9% sodium 
chloride containing 2% sodium nitrite as a vasodilator, followed 
by 250 ml of 4% paraformaldehyde in 0.1 M phosphate buffer 
containing 2.5% acrolein (Polysciences, Warrington, PA, USA). 
Following fi xation, a fi nal rinse with the sodium chloride/sodium 
nitrite solution was used to remove residual acrolein from the ani-
mal. Immediately after perfusion, the brains were removed and the 
tissue stored at 4°C in 30% sucrose solution until sectioned. The 
brains were cut into 30-µm coronal sections with a Leica 2000R 
freezing microtome (Leica Microsystems, Wetler, Germany) and 
stored freely fl oating in cryoprotectant-antifreeze solution (Watson 
et al., 1986) at −20°C until immunohistochemical processing.
IMMUNOCYTOCHEMISTRY
A 1:6 series through the rostrocaudal axis of each brain was 
 processed for immunohistochemical localization of mu opioid 
receptor, beta-endorphin, met-enkephalin or leu-enkephalin. 
Briefl y, sections were removed from the cryoprotectant-antifreeze 
solution, rinsed extensively in potassium phosphate-buffered 
saline, and then reacted for 20 min in 1% sodium borohydride 
to remove excess  aldehydes. Sections were then incubated in pri-
mary antibody solution in potassium phosphate buffer solution 
(KPBS) containing 0.1% Triton X for 1 h at room temperature, 
followed by 48 h at 4°C. Mu immunoreactivity was identifi ed 
using the polyclonal rabbit anti-MOR antibody at a  concentration 
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of 1:35,000 (Chemicon; Billerica, MA, USA). Beta-endorphin 
 immunoreactivity was recognized using the polyclonal rabbit anti-
beta-endorphin antibody at a concentration of 1:30,000 (Peninsula 
Labs; Torrance, CA, USA). Met- and leu-enkephalin immunoreactiv-
ity were identifi ed using the polyclonal rabbit anti-met-enkephalin 
and anti-leu-enkephalin antibodies at concentrations of 1:50,000 
(Immunostar; Hudson, WI, USA) and 1:200,000 (Immunostar; 
Hudson, WI, USA), respectively. After rinsing in KPBS, the tissue 
was incubated for 1 h in biotinylated goat-anti-rabbit IgG (Jackson 
Immunoresearch, West Grove PA, USA; 1:200), rinsed again, and 
incubated for 1 h in  avidin-biotin peroxidase complex (ABC Elite 
Kit, Vector, Burlingame, CA, USA; 1:10). After rinsing in KPBS and 
sodium acetate (0.175 M; pH 6.5), antigens were visualized using 
nickel sulfate-intensifi ed 3,3′-diaminobenzidine solution contain-
ing 0.08% hydrogen peroxide in sodium acetate buffer. The reac-
tion product was terminated after 20–30 min by rinsing in sodium 
acetate buffer. Sections were mounted out of saline onto gelatin-
subbed slides, air dried overnight, dehydrated in a series of graded 
alcohols, cleared in xylene, and coverslipped with Permount.
DENSITOMETRY
The PAG was divided into three rostrocaudal levels: (Rostral: Bregma 
−6.72 to −7.04; Mid: Bregma −7.30 to −8.00; Caudal: Bregma −8.30 
to −8.80), and the lateral/ventrolateral PAG (PAGl/vl) was analyzed 
for each section as previously described (Loyd et al., 2008). The 
lateral/ventrolateral region was targeted based on previous studies 
demonstrating that this region contains a high density of MOR 
mRNA and protein (Commons et al., 2000; Wang and Wessendorf, 
2002). Briefl y, 12-bit grayscale images of each section were captured 
with a 2×, 4× and 20× objective on a Nikon Eclipse E800 micro-
scope using a Sensys digital camera (Biovisions Technology; Exton, 
PA, USA). Quantitative analysis was performed using IP Spectrum 
software (Scanalytics; Fairfax, VA, USA). The PAGl/vl was sampled 
for three sections per animal and the average grayscale pixel value 
(ODU; optical density units) was recorded per rostrocaudal level. 
Measures were corrected for nonspecifi c binding by subtraction of 
background measures taken from areas lacking immunoreactivity 
adjacent to the PAGl/vl.
RECEPTOR AUTORADIOGRAPHY
Neonatally manipulated male and female rats were sacrifi ced on P60 by 
decapitation. Brains were quickly removed, fl ash-frozen on dry ice and 
stored at −80°C. Next, brains were sectioned at 20 µm thickness with a 
Leica CM3050S cryostat, and immediately mounted onto Super-frost 
slides and stored at −80°C until the time of assay. For radiographical 
processing, sections were allowed to thaw to room temperature and 
then immersed in 0.1% paraformaldehyde for 2 min to optimize tissue 
integrity. Sections then were rinsed in 50 mM Tris-NaCl (pH 7.4) at 
room temperature for 15 min followed by a 15-min rinse in 50 nM 
Tris (pH 7.4). Next, the tissue sections were incubated for 60 min at 
room temperature in a solution of 50 mM Tris (pH 7.4) with 10 mM 
MgCl
2
 and 0.1% bovine serum albumin. 3 nm [3H]-Naltrindole 
(20 Ci/mmol; NIDA) was added to label delta receptor binding or 
1 nm [3H]-DAMGO (56.8 Ci/mmol; Perkin Elmer/NEN, MA, USA) 
was added to label mu receptor binding. Following incubation, sec-
tions were washed three times at 10 min each in 50 mM Tris-HCl 
(pH 7.4) with 10 mM MgCl
2
 at room temperature,  followed by a fi nal 
dip in cold dH
2
O. Sections were allowed to air-dry  overnight and were 
then apposed to FujiFilm imaging plates along with [3H]-microscale 
standards (Perkin-Elmer/NEN, MA, USA) for 4 weeks. Film plates 
were processed using a FujiFilm BAS 5000. Autoradiographic [3H]-
receptor binding was quantifi ed from fi lm using MultiGauge software 
(FujiFilm, USA). [3H]-standards were used to convert uncalibrated 
optical density to disintegrations per minute (DPM). For analysis, the 
PAG was divided into three rostrocaudal levels as described above, 
and DPM were determined for the lateral/ventrolateral subdivision 
of each level. A mean for each level (rostral, mid, caudal) for each 
animal was then calculated.
STATISTICAL ANALYSIS AND DATA PRESENTATION
All values are reported as Mean ± SEM. Behavioral data are 
expressed as raw withdrawal latencies. Signifi cant main effects 
of neonatal treatment and sex were assessed using ANOVA or 
Repeated Measures ANOVA; p < 0.05 was considered statisti-
cally signifi cant. Sheffe post-hoc tests were conducted to deter-
mine signifi cant mean differences between groups that were 
apriori specifi ed. Anatomical data are expressed either as optical 
 density units (ODU; immunohistochemistry) or disinigrations 
per minute (DPM; autoradiography). For data presentation, a 
 representative animal from each experimental group was selected. 
Photomicrographs were generated using a Synsys digital camera 
attached to a Nikon Eclipse E800 microscope. Images were cap-
tured with IP Spectrum software and fi nalized in Adobe Photoshop 
7.0. Alterations to the images were strictly limited to enhancement 
of brightness and contrast.
RESULTS
NEONATAL INJURY ALTERS OPIOID TONE
To test the hypothesis that neonatal injury results in upregu-
lated opioid tone in adulthood, neonatally manipulated male 
and female rats received a systemic injection of the non-selective 
opioid antagonist naloxone HCl (1 mg/kg; i.p.) or saline control 
15 min prior to behavioral testing at P60. Neonatally injured 
(1% CGN) animals that were administered saline (n = 6–8/sex) 
in adulthood displayed signifi cantly increased PWLs compared to 
control animals (F(5,39) = 53.54, p < 0.05; Figure 1A). This injury-
induced hypoalgesia was signifi cantly greater in neonatally-injured 
females compared to males, as previously reported (LaPrairie and 
Murphy, 2007). In contrast, neonatally injured males and females 
(n = 6–8/sex) that received systemic naloxone HCl in adulthood 
displayed PWLs of approximately 9–10 s, not signifi cantly different 
from withdrawal latencies in uninjured control animals (p > 0.05; 
Figure 1A). Indeed, opioid receptor blockade by systemic naloxone 
completely reversed the neonatal injury-induced hypoalgesia in 
both males and females, suggesting that the long-term hypoalgesia 
observed in neonatally injured animals is due to altered endogenous 
opioid tone.
ALTERATIONS IN OPIOID TONE ARE CENTRALLY, AND NOT 
PERIPHERALLY, MEDIATED
Opioid receptors are present both centrally and peripherally (Hiller 
et al., 1994). To determine whether changes in peripheral opioid 
tone contributed to effects observed with systemic naloxone HCl, 
adult animals were administered the peripherally restricted opioid 
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antagonist naloxone methiodide (1 mg/kg) prior to behavioral 
 testing. This dose has been previously shown to block the periph-
eral but not central effects of morphine (Ji et al., 2006).
Administration of the naloxone methiodide had no effect on 
neonatal injury-induced hypoalgesia (Figure 1B). In contrast, 
intracerebroventricular administration of naloxone HCl (1 µg/2 µl), 
signifi cantly decreased PWLs in neonatally injured animals to 
control levels at 30-min post-administration (F(12,132) = 15.87, 
p < 0.05; Figure 1C). Withdrawal latencies in injured animals 
returned to pre-injection levels 120-min following administration 
of naloxone HCl. In contrast, i.c.v. naloxone HCl had no effect 
on withdrawal latencies in handled and saline control animals. 
Together, these results suggest that neonatal infl ammation results 
in persistent changes in opioid tone that are centrally mediated.
CHANGES IN OPIOID TONE ARE MEDIATED WITHIN THE PAG
The PAG is an essential substrate for opioid-induced analgesia 
(Basbaum and Fields, 1978, 1984; Fields et al., 1991). To test the 
hypothesis that neonatal injury-induced alterations in opioid tone 
were mediated within the PAG, we administered naloxone HCl directly 
into the mid ventrolateral PAG (PAGvl) in neonatally injured and 
control animals. Intra-PAGvl naloxone (0.5 µg/0.5 µl) signifi cantly 
reduced PWLs in neonatally injured males and females at 15 min 
post-injection (F(12,144) = 8.95, p < 0.05; Figure 1D). No effect of 
intra-PAGvl naloxone was noted on PWLs in control animals.
The PAG contains mu, delta and kappa receptors (Mansour et al., 
1995); therefore, to determine which opioid receptor subtype(s) in the 
PAG contribute to alterations in opioid tone, we administered recep-
tor specifi c opioid antagonists. Intra-PAGvl administration of the mu 
receptor antagonist, CTOP (7.5 µg/0.5 µl) signifi cantly reduced PWLs 
in injured males and females to a level comparable to control values at 
30 min post-injection (F(12,108) = 9.21, p < 0.05; Figure 2A). Intra-
PAGvl naltrindole (7.5 µg/0.5 µl), a delta-selective antagonist, also 
signifi cantly decreased PWLs to control levels, but only in neonatally 
injured females (F(12,144) = 2.92, p < 0.05; Figure 2B). In males, the 
effects of intra-PAGvl naltrindole were limited to the fi rst 15 min 
post-injection, with only a slight, albeit signifi cant, decrease in PWLs 
observed. Intra-PAGvl administration of nor-BNI did not signifi cantly 
reduce withdrawal latencies in injured males or females: signifi cant 
main effect of injury, F(2,42) = 474.25, p < 0.05; Figure 2C.
FIGURE 1 | (A) Administration of naloxone HCl to neonatally injured animals 
(CGN/NAL) prior to testing at P60 signifi cantly lowered PWLs in comparison to 
injured animals that received saline (CGN/SAL). Administration of naloxone HCL to 
saline (SAL/NAL) or handled (HAN/NAL) controls had no effect. (B) Administration 
of naloxone methiodide (NAL-M) to neonatally injured (CGN/NAL-M) animals at 
P60 had no signifi cant effect on PWLs compared to injured animals that received 
saline (CGN/SAL). Neonatally injured animals (CGN/NAL-M and CGN/SAL) 
displayed signifi cantly higher PWLs compared to saline (SAL/NAL-M and 
SAL/SAL) and handled (HAN/NAL-M and HAN/SAL) controls. (C) Neonatally injured 
males (?) and females (?) displayed signifi cantly reduced PWLs during the 
120 min following i.c.v. or (D) intra-PAG administration of naloxone HCl compared 
to handled males (?) or females (?) and saline males (?) and females (?). 
N = 6–8 rats per group/per sex. In panels (A) and (B): * denotes signifi cant main 
effect of treatment; # denotes signifi cant main effect of sex; in panels (C) and 
(D) – * indicates that PWLs for injured animals (collapsed across sex) were 
signifi cantly different from controls. Error bars represent SEM.
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INJURY-INDUCED INCREASE BETA-ENDORPHIN AND 
MET/LEU-ENKEPHALIN IMMUNOREACTIVITY IN THE PAG
The next series of experiments used immunohistochemistry and 
receptor autoradiography to determine whether our behavioral 
pharmacological results refl ected changes in endogenous opioid 
peptide and/or receptor expression within the PAG.
Beta-endorphin, an endogenous opioid neuropeptide that has the 
highest affi nity for mu opioid receptors, was signifi cantly increased 
in the lateral/ventrolateral (l/vl) region of the mid (F(1,16) = 4.62, 
p < 0.05) and caudal (F(1,16) = 6.57, p < 0.05) PAG in neona-
tally injured males and females compared to handled controls 
(Figure 3). Increases in beta-endorphin were primarily evidenced 
as an increase in the number of immunoreactive fi bers within the 
ventrolateral PAG. No signifi cant injury effects were observed in 
the rostral PAG. Moreover, no signifi cant sex  differences in beta-
 endorphin  expression were detected at any level of the PAG.
Neonatal injury also induced changes in the expression of the 
DOR preferring ligands, met-and leu-enkephalin. Specifi cally, neo-
natally injured males and females displayed signifi cantly increased 
met- and leu-enkephalin immunoreactivity in the l/vl region of the 
mid (met: F(1,20) = 29.50, p < 0.05; leu: F(1,20) = 14.92, p < 0.05) 
and caudal (met: F(1,20) = 50.88, p < 0.05; leu: F(1,20) = 13.23, 
p < 0.05) levels of the PAG compared to controls (Figure 4). For 
both met- and leu-enkephalin, neonatal injury induced an increase 
in both the number and density of fi ber staining; changes in immu-
noreactivity were primarily limited to the lateral PAG. A signifi -
cant effect of sex was noted within the mid and caudal PAGl/vl for 
met-enkephalin, such that injured females displayed signifi cantly 
more immunoreactive fi bers compared to injured males (mid: 
F(1,20) = 5.39, p < 0.05; caudal: F(1,20) = 4.72, p < 0.05).
DECREASED MOR AND DOR BINDING IN THE PAG
We next used autoradiography to determine if neonatal injury 
was also associated with changes in opioid receptor binding. 
Neonatally injured males and females displayed signifi cantly 
reduced MOR binding at all rostral-caudal levels of the PAGl/vl 
compared to handled controls (rostral: F(1,20) = 58.46, p < 0.05; 
mid: F(1,20) = 286.50, p < 0.05; caudal: F(1,20) = 78.89, p < 0.05; 
Figure 5). Immunohistochemistry was also used to confi rm our 
observed decrease in PAG MOR expression. Similar to what we 
observed using autoradiography, neonatal injury resulted in a 
signifi cant decrease in MOR immunoreactivity (primarily due 
to decreased fi ber staining) within the mid (F(1,20) = 26.34, 
p < 0.05) and caudal (F(1,20) = 31.51, p < 0.05) levels of the 
PAGl/vl (Figure 6). Neonatal injury induced decreases in MOR 
were also evident within the dorsolateral PAG.
A signifi cant decrease in DOR binding was also observed at the 
mid level (F(1,20) = 22.41, p < 0.05) of the PAGl/vl in neonatally 
injured females compared to all other groups (Figure 5). The sexu-
ally dimorphic expression of DOR binding in injured animals is 
consistent with our behavioral effects showing sex-specifi c effects of 
intra-PAG naltrindole on baseline thermal sensitivity (Figure 2B). 
As there are no DOR-specifi c antibodies that are commercially 
available, corroboration of the binding data with immunocyto-
chemistry could not be performed.
DISCUSSION
Our principle fi nding is that the hypoalgesia induced by neona-
tal infl ammatory insult is mediated by changes in mu and delta, 
but not kappa, opioid tone within the PAG, as indicated by an 
increase in endogenous opioid peptide expression (beta-endorphin 
and met/leu-enkephalin), and a concomitant decrease in mu and 
delta opioid receptor binding. Changes in delta opioid tone were sex 
specifi c, and may contribute to the potentiated effects of neonatal 
injury observed in females.
The periaqueductal gray (PAG), and its descending projec-
tions to the rostral ventromedial medulla (RVM) and the spinal 
cord dorsal horn, constitute a primary anatomical circuit for the 
descending modulation of pain (Basbaum and Fields, 1984). The 
PAG is rich in nerve terminals and fi bers containing endogenous 
FIGURE 2 | (A) Intra-PAGvl CTOP signifi cantly reduced PWLs in neonatally 
injured males (?) and females (?) compared to controls. (B) Neonatally 
injured females displayed signifi cantly reduced PWLs following intra-PAGvl 
naltrindole that were not signifi cantly different from handled and saline 
controls. In males, intra-PAGvl naltrindole resulted in a slight decrease in 
PWLs. (C) Administration of nor-BNI into the PAGvl had no signifi cant effect on 
PWLs in neonatally injured or control animals. N = 6–8 rats per group/per sex. 
* indicates that PWLs for injured animals (collapsed across sex) were 
signifi cantly different from controls.
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persistent (lasting approximately 48–72 h), the release of endog-
enous opioids is sustained, and this continuous opioid release, dur-
ing a time of increased developmental plasticity, is subsequently 
maintained into adulthood. Previous studies have reported that 
increased afferent drive during the developmental critical period 
results in the reorganization of somatosensory circuits in adult-
hood (Tropea et al., 2006). Indeed, changes in endogenous pain 
modulation in humans as a consequence of neonatal pain has been 
previously proposed to account for the long term changes in pain 
sensitivity observed in NICU infants exposed to frequent noxious 
interventions (Goffaux et al., 2008).
In the present study, we report a signifi cant increase in PAG opioid 
peptide expression as a consequence of neonatal injury, and it is 
notable that alterations in the endorphin and enkephalinergic sys-
tems were very well correlated across similar regions and levels of the 
PAG. This suggests that the two opioidergic systems act in parallel in 
response to neonatal infl ammation and nociception. While compa-
rable studies have not been conducted in neonates,  previous studies 
opioids (Reichling et al., 1988), and opioid receptors are localized 
throughout the rostral-caudal axis of the PAG (Mansour et al., 
1995). Interestingly, while in rats the anatomical connections for 
nociceptive modulation are present at birth, descending inhibitory 
controls are functionally immature throughout the fi rst postnatal 
weeks (Fitzgerald and Koltzenburg, 1986; Boucher et al., 1998). 
The delayed maturation of descending inhibition may therefore 
contribute to the increased vulnerability of the immature soma-
tosensory system to excessive afferent input, whereby exposure to 
neonatal noxious stimulation during a critical window may alter 
the functional integrity of endogenous descending inhibitory sys-
tems. In reference to the present results, our working hypothesis is 
that neonatal injury during this critical developmental period (P0–
P8; LaPrairie and Murphy, 2007) results in increased afferent drive 
to CNS sites responsive to noxious input (e.g. PAG). This increased 
drive results in the activation of endogenous pain inhibitory cir-
cuits and the subsequent release of endogenous opioid peptides. 
As the infl ammation associated with intraplantar  carrageenan is 
FIGURE 3 | Photomicrograph depicting representative examples of beta-endorphin-ir in the PAGl/vl in adult rats following neonatal treatment. 
(A) handled, 4×, (B) handled, 20×; (C) 1% carrageenan, 20×. (D) Neonatal CGN resulted in signifi cantly increased beta-endorphin-ir in the lateral/ventrolateral regions 
of the mid and caudal PAG compared to control animals. N = 6–8 rats per group/per sex. * denotes signifi cant main effect of treatment. Error bars represent SEM.
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FIGURE 4 | Photomicrograph depicting met- and leu-enkephalin-ir at mid-level PAG in adult rats following neonatal handling (A,C) or intraplantar 
CGN (B,D). A signifi cant increase in met- and leu-enkephalin-ir (panels E and F, respectively) was noted in neonatally-injured animals compared to controls at all 
rostral-caudal levels of the PAG. N = 6–8 rats per group/per sex. * denotes signifi cant main effect of treatment; # denotes signifi cant main effect of sex. Error bars 
represent SEM.
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in adult rats have reported that hindpaw  infl ammation results in 
upregulated biosynthesis of pro-dynorphin and pro-enkephalin in 
dorsal horn neurons (Iadarola et al., 1988; Noguchi et al., 1989), and 
a signifi cant increase in endogenous opioid peptide release within the 
PAG (Williams et al., 1995). Noxious stimulation-induced changes 
in opioid peptide expression are also paralleled by an increase in 
mRNA expression (Iadarola et al., 1988). As stated above, our work-
ing hypothesis is that neonatal infl ammation results in the release 
of endogenous opioid peptides within the PAG as a mechanism 
of decreasing nociception. It is not clear why a parallel decrease in 
opioid receptor expression was also noted. However, previous studies 
have similarly reported a long-term increase in endogenous opioid 
peptide along with a concomitant decrease in mu and delta opioid 
receptor density in the lateral hypothalamus of offspring following 
gestational stress (Sanchez et al., 1996, 2000). Alternatively, opioid 
receptors are rapidly internalized following ligand binding, which 
would also result in a concomitant decrease in opioid receptor avail-
ability. Taken together, these studies suggest that early life pain can 
confer long-lasting changes in supraspinal opioidergic circuits that 
are refl ected by changes in peptide and receptor expression.
In the present study, intra-PAG naloxone signifi cantly reduced 
neonatal injury-induced hypoalgesia suggesting a locus for injury-
induced changes. However, neonatal infl ammatory insult may 
induce changes in opioid tone in other sites, including the RVM and 
spinal cord. Indeed, increased brain and spinal cord  immunoreactive 
beta-endorphin, met-enkephalin and dynorphin, as well as decreased 
opioid receptor binding has been reported  following peripheral 
infl ammation in adult rats (Cesselin et al., 1980; Millan et al., 1986; 
Spetea et al., 2002). Therefore, while the results of our site-specifi c 
antagonist injections suggest that changes in the PAG are necessary 
and suffi cient for the observed effects of neonatal injury, changes in 
additional CNS sites cannot be excluded.
A signifi cantly greater increase in met-enkephalin was observed in 
neonatally injured females compared to males. This differential change 
in peptide expression may contribute to the increased hypoalgesia 
observed in females. No signifi cant sex difference in met-enkephalin 
immunoreactivity was present at baseline, indicating that the observed 
sex differences were injury-induced. Although not investigated in the 
present study, endomorphins also play an important role in the modu-
lation of descending controls, and possess partial agonist properties 
at mu-receptor sites in the PAG (Zadina et al., 1997).
While the results of the present study strongly suggest that 
persistent alterations in baseline nociceptive thresholds associ-
ated with neonatal infl ammatory insult are mediated by a central 
increase in endogenous opioid tone, additional mechanisms may 
also contribute. Noxious neonatal experiences lead not only to 
decreased nociceptive sensitivity in adulthood, but also to signifi -
cant alterations in the behavioral and neuroendocrine responses to 
stress (Bernardi et al., 1986; Anand et al., 1999; Bhutta et al., 2001; 
Schellinck et al., 2003; Sternberg and Ridgway, 2003; Sternberg et al., 
FIGURE 5 | MOR binding in the PAG in adult rats following (A) handling, 
or (B) 1% carrageenan. DOR binding distribution in the PAG of adult rats 
following (C) handling, or (D) 1% carrageenan. (E) Neonatally injured (CGN) 
animals displayed a signifi cant decrease in MOR-binding at all levels of the 
PAGl/vl compared to handled animals. (F) A signifi cant decrease in 
DOR-binding was noted in neonatally injured females in comparison to all 
other groups in the mid PAGl/vl. A signifi cant main effect of sex was also 
observed at this level. N = 6 rats per group/per sex. * denotes signifi cant main 
effect of treatment; # denotes signifi cant main effect of sex. Error bars 
represent SEM.
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receptors due to enhanced release of endogenous opioid peptides. 
This decrease in receptor availability is supported by our previous 
fi ndings demonstrating a signifi cant rightward shift in the mor-
phine dose-response curve in adult animals that were neonatally-
injured (LaPrairie et al., 2008). Similar results have been reported in 
children, such that the number of invasive procedures experienced 
in the neonatal intensive care unit are inversely correlated with 
morphine effectiveness (Grunau et al., 2001). Despite the current 
knowledge that neonates are responsive to noxious stimuli, the 
majority of routine procedures, including repeated heel-lances, 
endotracheal intubations and minor surgeries are performed in 
the absence of analgesics (Simons et al., 2003). Indeed recent stud-
ies have reported that neonates receiving NICU treatment experi-
ence an average of 14 noxious procedures per day, with fewer than 
35% receiving appropriate analgesic therapy (Simons et al., 2003). 
Demonstration that neonatal injury results in long-term changes in 
opioid tone and sensory thresholds may have serious implications 
for future pain management in neonates.
2005). Blunted emotionality, decreased anxiety, and reduced basal 
and stress induced plasma corticotropin releasing factor (CRF) and 
adrenocorticotropin hormone (ACTH) are displayed in adult rats 
following short-lasting, local infl ammation experienced during the 
fi rst week of life (Bhutta et al., 2001; Anseloni et al., 2005). Premature 
infants with extensive NICU care also exhibit low basal levels of 
stress hormones at 3 months of age compared to their full-term 
counterparts (Grunau et al., 2007). Thus, alterations in the develop-
ing hypothalamic–pituitary–adrenal axis may also contribute to the 
long-term basal hypoalgesia following neonatal hindpaw infl amma-
tion. Indeed neonatal noxious stimulation may produce a general-
ized reduction in reactivity to aversive environmental stimuli due to 
parallel alterations in supraspinal nociceptive and stress modulatory 
circuits (Ren et al., 2004; Anseloni et al., 2005). Ongoing studies in 
our laboratory are currently testing this hypothesis.
In summary, the present study demonstrated that persistent 
pain experienced early in life results in decreased mu and delta 
receptor availability, suggesting a persistent activation of opioid 
FIGURE 6 | Photomicrograph depicting representative examples of MOR-ir 
in the PAGl/vl in adult rats following neonatal treatment. (A) handled, 4×, 
(B) handled, 10×, (C) 1% carrageenan, 10×. (D) At mid and caudal levels of PAG, 
CGN animals expressed signifi cantly lower MOR-ir compared to handled 
animals. N = 6–8 rats per group/per sex. * denotes signifi cant main effect of 
treatment. Error bars represent SEM.
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